A detailed history of Archon Capital Management LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Archon Capital Management LLC holds 2,473,269 shares of STIM stock, worth $2.7 Million. This represents 3.67% of its overall portfolio holdings.

Number of Shares
2,473,269
Previous 2,537,097 2.52%
Holding current value
$2.7 Million
Previous $12.1 Million 63.14%
% of portfolio
3.67%
Previous 4.16%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.73 - $4.81 $110,422 - $307,012
-63,828 Reduced 2.52%
2,473,269 $4.45 Million
Q4 2023

Feb 13, 2024

SELL
$1.05 - $2.9 $357,639 - $987,766
-340,609 Reduced 11.84%
2,537,097 $7.36 Million
Q3 2023

Nov 13, 2023

BUY
$1.29 - $2.22 $553,344 - $952,266
428,949 Added 17.52%
2,877,706 $3.88 Million
Q2 2023

Aug 11, 2023

BUY
$2.07 - $2.92 $1.5 Million - $2.12 Million
725,007 Added 42.06%
2,448,757 $5.26 Million
Q1 2023

May 12, 2023

SELL
$2.81 - $6.71 $286,777 - $684,795
-102,056 Reduced 5.59%
1,723,750 $5.02 Million
Q2 2022

Aug 15, 2022

BUY
$2.09 - $3.71 $51,875 - $92,085
24,821 Added 1.38%
1,825,806 $5.86 Million
Q1 2022

May 16, 2022

SELL
$2.84 - $4.52 $151,741 - $241,503
-53,430 Reduced 2.88%
1,800,985 $5.46 Million
Q4 2021

Feb 14, 2022

BUY
$3.87 - $6.59 $1.08 Million - $1.84 Million
279,220 Added 17.73%
1,854,415 $8.27 Million
Q3 2021

Nov 15, 2021

BUY
$6.22 - $15.54 $1.56 Million - $3.89 Million
250,000 Added 18.87%
1,575,195 $10.3 Million
Q2 2021

Aug 16, 2021

BUY
$10.15 - $17.25 $1.14 Million - $1.94 Million
112,300 Added 9.26%
1,325,195 $21.2 Million
Q1 2021

May 14, 2021

BUY
$10.6 - $21.27 $1.57 Million - $3.16 Million
148,475 Added 13.95%
1,212,895 $15 Million
Q3 2020

Nov 13, 2020

BUY
$1.82 - $5.87 $1.94 Million - $6.25 Million
1,064,420 New
1,064,420 $5.17 Million

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $29.5M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Archon Capital Management LLC Portfolio

Follow Archon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archon Capital Management LLC with notifications on news.